Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of eight immune gene signatures in pancreatic cancer patients.

BMC medical genomics·2021
Same author

PPD: A Manually Curated Database for Experimentally Verified Prokaryotic Promoters.

Journal of molecular biology·2021
Same author

Generation of an induced pluripotent stem cell line from a Chinese Han infant with floating-harbor syndrome accompanied with dilated cardiomyopathy.

Stem cell research·2021
Same author

Identification of Key Histone Modifications and Their Regulatory Regions on Gene Expression Level Changes in Chronic Myelogenous Leukemia.

Frontiers in cell and developmental biology·2021
Same author

DM3Loc: multi-label mRNA subcellular localization prediction and analysis based on multi-head self-attention mechanism.

Nucleic acids research·2021
Same author

Label-free exonuclease I-assisted signal amplification colorimetric sensor for highly sensitive detection of kanamycin.

Food chemistry·2021

Related Experiment Video

Updated: Apr 21, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K

Alpha-synuclein seed amplification assays differentiate synucleinopathies.

Wei Dai1,2, Hao Lin3,4, Hengxu Mao3

  • 1Department of Neurology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.

Expert Review of Molecular Diagnostics
|April 19, 2026
PubMed
Summary

Alpha-synuclein seed-amplification assays (α-syn SAAs) show promise for diagnosing synucleinopathies like Parkinson's disease. Optimizing these assays can differentiate between disease subtypes for improved accuracy.

Keywords:
Parkinson’s diseasekineticsseed amplification assaysynucleinopathiesα-synuclein aggregation

More Related Videos

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.8K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.3K

Related Experiment Videos

Last Updated: Apr 21, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.8K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.3K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Synucleinopathies involve misfolded alpha-synuclein (α-syn) aggregation, forming Lewy bodies or glial inclusions.
  • Alpha-synuclein seed-amplification assays (α-syn SAAs) are highly sensitive and specific for detecting synucleinopathies.

Purpose of the Study:

  • To review α-syn strain propagation in Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).
  • To summarize factors influencing SAA kinetics.
  • To identify optimal modulation of SAA parameters for distinct kinetic signatures, enabling biochemical diagnosis.

Main Methods:

  • Review of literature on α-syn strain propagation and SAA kinetics.
  • Analysis of biophysical and procedural variables affecting SAA performance.
  • Exploration of strategies to achieve subtype-specific kinetic signatures.

Main Results:

  • Distinct α-syn strains propagate differently across synucleinopathy subtypes.
  • SAA kinetics are influenced by various biophysical and procedural factors.
  • Modulating SAA parameters can potentially yield distinct kinetic signatures for each subtype.

Conclusions:

  • α-Syn SAAs have the potential for routine use in differentiating synucleinopathy subtypes.
  • Standardization of protocols and further research into α-syn strain propagation mechanisms are crucial.
  • Insights gained can inform the development of novel therapeutic strategies.